<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2919275/" ref="ordinalpos=2973&amp;ncbi_uid=3057870&amp;link_uid=PMC2919275" image-link="/pmc/articles/PMC2919275/figure/F2/" class="imagepopup">Fig. 2. PD-1 <span class="highlight" style="background-color:">signaling</span>.  From: The PD-1 <span class="highlight" style="background-color:">Pathway</span> in Tolerance and Autoimmunity. </a></div><br /><div class="p4l_captionBody">Ligation of TCR and PD-1 leads to tyrosine phosphorylation (P) of the ITIM and ITSM of PD-1. Binding of the ITSM by SHP-1 or SHP-2 results in the dephosphorylation of proximal signaling molecules and augmentation of PTEN expression. This effectively attenuates the activation of the PI3K and Akt pathways. PD-1 signaling may result in decreased T-cell proliferation, survival, protein synthesis, and IL-2 production. (Red arrows and text indicate consequence of PD-1-mediated signaling)</div></div>